Media
Insights from Ron
“Anyone who has never made a mistake has never tried anything new.”
Albert Einstein
2022 Cancer Highlights
The year 2022 marked another major step in the quest to towards making cancer history. Below are several highlights among ...
Read More →
Targeting T cell Checkpoints and Myeloid Suppressors is an Effective Immunotherapy in Pancreas Cancer
Pat Gulhati1and Ronald DePinho2 1Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. 1Department ...
Read More →
Opportunity in the Biomedical Roller Coaster
Even in this market meltdown, seasoned biotech innovators with decades of experience know that strong novel science in the hands ...
Read More →
The Battle for Foundational Research Funding
Twentieth-century health activist Mary Lasker, who devoted her life to securing greater research funding for cancer, is quoted as saying: ...
Read More →
Synthetic Essentiality of Tryptophan 2,3-dioxygenase 2 in APC-Mutated Colorectal Cancer
Inactivation of the adenomatous polyposis coli (APC) is common across many cancer types and serves as a critical initiating event ...
Read More →
Fungal Mycobiome Drives IL-33 Secretion and Type 2 Immunity in Pancreatic Cancer
Paradigmatic work from PJ Dey’s Lab reveals the co-conspiratory roles of oncogenic KRAS and intratumoral fungi in promoting immune modulating ...
Read More →